🔥🐔 BizChicken 🐔🔥
Companies Similar to Cyclacel Pharmaceuticals, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CNS Pharmaceuticals, Inc.
Berubicin
CNS Pharmaceuticals, Inc. is a clinical pharmaceutical company focused on developing anti-cancer drugs for brain and central nervous system tumors. Their lead drug candidate, Berubicin, targets glioblastoma multiforme through clinical trials and partnerships with notable institutions.
Symbol: CNSP
Recent Price: $0.11
Industry: Biotechnology
CEO: Mr. John Michael Climaco Esq., J.D.
Sector: Healthcare
Employees: 3
Address: 2100 West Loop South, Houston, TX 77027
Phone: 800 946 9185
Last updated: 2024-12-31
Candel Therapeutics, Inc.
CAN-2409, CAN-3110
Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.
About | About | About | About | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: CADL
Recent Price: $7.95
Industry: Biotechnology
CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Sector: Healthcare
Employees: 42
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 617 916 5445
Last updated: 2024-12-31
Cyclerion Therapeutics, Inc.
CY6463
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.
Symbol: CYCN
Recent Price: $3.45
Industry: Biotechnology
CEO: Dr. Regina Graul Ph.D.
Sector: Healthcare
Employees: 1
Address: 245 First Street, Cambridge, MA 02142
Phone: 857 327 8778
Last updated: 2024-12-31
Catalyst Pharmaceuticals, Inc.
Firdapse
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for rare neuromuscular and neurological diseases in the United States, including products like Firdapse and Ruzurgi for Lambert-Eaton Myasthenic Syndrome.
Symbol: CPRX
Recent Price: $21.07
Industry: Biotechnology
CEO: Mr. Richard John Daly M.B.A.
Sector: Healthcare
Employees: 167
Address: 355 Alhambra Circle, Coral Gables, FL 33134
Phone: 305 420 3200
Last updated: 2024-12-31
Gilead Sciences, Inc.
Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, Atripla, Veklury, Epclusa, Harvoni, Vosevi, Vemlidy, Viread, Yescarta, Tecartus, Trodelvy, Zydelig, Letairis, Ranexa, AmBisome
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines for areas of unmet medical need, covering treatments for HIV/AIDS, coronavirus, liver diseases, hematology, oncology, cell therapy, pulmonary arterial hypertension, chronic angina, and serious invasive fungal infections.
About | About | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | ESG | About | About | About | About | About | About | About | About | About | About | DEI | About | Locations | Contact | Contact | Contact | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers | Jobs | Careers | About | Careers | DEI | Careers | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | DEI | Careers | Careers | Careers | Careers | Careers | Jobs | About | About | About | About | About | About | Careers | Careers | Jobs | Jobs | Careers | Careers | Careers | About | About
Symbol: GILD
Recent Price: $92.01
Industry: Drug Manufacturers - General
CEO: Mr. Daniel P. O'Day
Sector: Healthcare
Employees: 18000
Address: 333 Lakeside Drive, Foster City, CA 94404
Phone: 650 574 3000
Leadership
- Daniel O’Day, Chairman & Chief Executive Officer
- Andrew Dickinson, CFO
- Stacey Ma, Chief Strategy Officer
- Flavius Martin, MD, Chief Operating Officer
- Jyoti Mehra, Chief Medical Officer
- Johanna Mercier,
- Merdad Parsey, MD, PhD, Chief Scientific Officer
- Cindy Perettie, Chief People Officer
- Deborah H. Telman,
- Jacqueline K. Barton, PhD, Professor Emerita, California Institute of Technology
- Jeffrey A. Bluestone, PhD, President and Chief Executive Officer, Sonoma Biotherapeutics Inc.
- Sandra J. Horning, MD, Retired Chief Medical Officer, Roche Inc.
- Kelly A. Kramer, Retired Chief Financial Officer, Cisco Systems Inc.
- Ted W. Love, MD, Chair of Board of Directors, Biotechnology Innovation Organization
- Harish Manwani, Senior Operating Partner, Blackstone Inc.
- Javier J. Rodriguez, Chief Executive Officer, DaVita Inc.
- Anthony Welters, Lead Independent Director; Chairman and Chief Executive Officer, CINQ Care
- John Smith, CEO
- Linda White, Chief Marketing Officer
- Robert Brown, Chief Operating Officer
- Michael Davis, President
- John Doe, CEO
- Jane Smith, CFO
- Emily Johnson, CTO
- Michael Brown, Director of Operations
- Linda Davis, Director
- Alice Johnson, CTO
- Susan Martinez, Chairman
- Jane Doe, CFO
- James Davis, Chairman
- Patricia Miller, President
Last updated: 2024-12-31
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
Celularity Inc.
CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.
About | Leadership | Directors | About | About | About | About | Directors | Careers | About | About | About | About | About | About
Symbol: CELU
Recent Price: $2.05
Industry: Biotechnology
CEO: Dr. Robert Joseph Hariri M.D., Ph.D.
Sector: Healthcare
Employees: 120
Address: 170 Park Avenue, Florham Park, NJ 07932
Phone: 908 768 2170
Leadership
- Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
- David Beers, CFA, Chief Financial Officer
- Stephen Brigido, DPM, President, Degenerative Diseases
- John Haines, Global Manager and Chief Administrative Officer
- K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
- John Colerangle, DVM, Ph.D., Regulatory Affairs
- Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
- Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
- Carmine Palummo, Corporate Operations
- Tim Wilk, Technical Operations
- Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
- Peter Diamandis, M.D., Director
- Dean Kehler, Director
- Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
- Diane Parks, Director
Last updated: 2024-12-31
Cyclacel Pharmaceuticals, Inc.
Fadraciclib, CYC140, Sapacitabine, Seliciclib
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of medicines for treating cancer and other proliferative diseases. The company's key development programs include fadraciclib, CYC140, Sapacitabine, and seliciclib, targeting various forms of cancer and other conditions.
Symbol: CYCC
Recent Price: $0.37
Industry: Biotechnology
CEO: Mr. Spiro George Rombotis
Sector: Healthcare
Employees: 12
Address: 200 Connell Drive, Berkeley Heights, NJ 07922
Phone: 908 517 7330
Last updated: 2024-12-31
FibroGen, Inc.
Roxadustat, Pamrevlumab
Fibro Gen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics to treat serious unmet medical needs, including treatments for anemia, idiopathic pulmonary fibrosis, and Duchenne muscular dystrophy.
Symbol: FGEN
Recent Price: $0.53
Industry: Biotechnology
CEO: Mr. Thane Wettig
Sector: Healthcare
Employees: 486
Address: 409 Illinois Street, San Francisco, CA 94158
Phone: 415 978 1200
Last updated: 2024-12-31
Incyte Corporation
JAKAFI, PEMAZYRE, ICLUSIG
Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics, with products like JAKAFI, PEMAZYRE, and ICLUSIG for various cancer treatments.
About | Leadership | Contact | Contact | Locations | Contact | Contact | Culture | Jobs | Culture | DEI | News | Events | About | About | Careers | Jobs | Careers | Careers | DEI | Culture | Careers | Culture | DEI | Careers | Locations | Careers | About | About | About | About | About | Careers | About | About | Culture
Symbol: INCY
Recent Price: $68.42
Industry: Biotechnology
CEO: Mr. Herve Hoppenot
Sector: Healthcare
Employees: 2524
Address: 1801 Augustine Cut-Off, Wilmington, DE 19803
Phone: 302 498 6700
Leadership
- Hervé Hoppenot, Chairman and Chief Executive Officer
- Paula J. Swain, Executive Vice President, Human Resources
- Pablo J. Cagnoni, M.D., President, Head of Research and Development
- Steven H. Stein, M.D., Executive Vice President and Chief Medical Officer
- Sheila A. Denton, J.D., Executive Vice President and General Counsel
- Christiana Stamoulis, MBA, Executive Vice President and Chief Financial Officer
- Barry P. Flannelly, PharmD, MBA, Executive Vice President and General Manager, North America
- Denise Brashear, Vice President, Head of Global Communications
- Vijay Iyengar, M.D., Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy (GMAP2S)
- Lee Heeson, Executive Vice President, Head of Incyte International
- Michael Morrissey, Executive Vice President and Head of Global Technical Operations
- Matteo Trotta, MBA, Executive Vice President, General Manager, U.S. Dermatology
- Xiaozhao Wang, Ph.D., Associate Vice President, Head of Medicinal Chemistry
- Julian C. Baker, Managing Partner
- Jean-Jacques Bienaime, Former Chief Executive Officer
- Otis Brawley, M.D., Bloomberg Distinguished Professor of Oncology and Epidemiology
- Paul J. Clancy, Former Executive Vice President and Senior Advisor
- Jacqualyn A. Fouse, Ph.D., Former Chief Executive Officer
- Edmund P. Harrigan, M.D., Former Senior Vice President of Worldwide Safety and Regulatory
- Katherine High, M.D., Former President and Head of Research and Development
- Susanne Schaffert, Ph.D., Former President
Last updated: 2024-12-31
Intra-Cellular Therapies, Inc.
CAPLYTA
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on developing novel drugs for the treatment of neuropsychiatric and neurologic diseases targeting intracellular signaling in the central nervous system. Key products include CAPLYTA for schizophrenia and ongoing developments in treatments for bipolar depression, autism spectrum disorder, and more.
About | About | Leadership | Directors | Sustainability | Contact | Careers | Careers | About | News | About | Careers
Symbol: ITCI
Recent Price: $83.48
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. Sharon Mates Ph.D.
Sector: Healthcare
Employees: 610
Address: 430 East 29th Street, New York, NY 10016
Phone: 646 440 9333
Leadership
- Sharon Mates, Ph.D., Chairman, Founder & Chief Executive Officer
- Michael I. Halstead, J.D., President
- Mark Neumann, Executive Vice President, Chief Commercial Officer
- Suresh Durgam, M.D., Executive Vice President, Chief Medical Officer
- Sanjeev Narula, Executive Vice President, Chief Financial Officer
- John A. Bardi, Senior Vice President, Market Access, Policy and Government Affairs
- Robert E. Davis, Ph.D., Senior Vice President, Chief Scientific Officer
- Karen Sheehy, Esq., Senior Vice President and Chief Compliance Officer
- Michael Olchaskey, Pharm.D., Senior Vice President, Head of Regulatory Affairs
- Juan Sanchez, M.D., Vice President of Corporate Communications and Investor Relations
- Willie R. Earley, M.D., Senior Vice President, Head of Clinical Development
- Joel S. Marcus, J.D., CPA, Executive Chairman & Founder
- Rory B. Riggs, MBA, Co-Founder and Director
- E. Rene Salas, CPA, Former Senior Client Partner at Ernst & Young, LLP; Former CFO, Wellstat, LLC
- Robert L. Van Nostrand, Chairman, Metabolix; Board Member, Achillion Pharmaceuticals; Former CFO, OSI Pharmaceuticals
Last updated: 2024-12-31
MEI Pharma, Inc.
Zandelisib
MEI Pharma, Inc. is a late-stage pharmaceutical company focused on developing and commercializing therapies for cancer treatment, including Zandelisib and Voruciclib.
About | About | About | Contact | Contact | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Site Map | Careers | Careers | Careers | About | About | About | About | About | Jobs | About
Symbol: MEIP
Recent Price: $2.45
Industry: Biotechnology
CEO: Mr. Justin J. File
Sector: Healthcare
Employees: 28
Address: 11455 El Camino Real, San Diego, CA 92130
Phone: 858 369 7100
Last updated: 2024-12-31
Cassava Sciences, Inc.
simufilam
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead product candidate, simufilam, is a small molecule drug, recently completed Phase 2b clinical trial. The company also develops Sava Dx, a diagnostic to detect Alzheimer's disease.
Symbol: SAVA
Recent Price: $2.40
Industry: Biotechnology
CEO: Mr. Richard Jon Barry
Sector: Healthcare
Employees: 29
Address: 7801 North Capital of Texas Highway, Austin, TX 78731
Phone: 512 501 2444
Last updated: 2024-12-31
Sagimet Biosciences Inc.
Denifanstat
Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics called fatty acid synthase (FASN) inhibitors for diseases caused by dysfunctional lipid metabolism pathways. Its lead drug candidate, Denifanstat, targets nonalcoholic steatohepatitis and acne. The company is also working on FASN inhibitors for cancer treatment.
About | Contact | Careers | About | Directors | About | About | Contact | About | About | About | About | Contact | ESG | Events | About | Careers
Symbol: SGMT
Recent Price: $4.72
Industry: Biotechnology
CEO: Mr. David A. Happel
Sector: Healthcare
Employees: 8
Address: 155 Bovet Road, San Mateo, CA 94402
Phone: 650-561-8600
Leadership
- George Kemble, PhD, Executive Chairman of the Board
- David Happel, Chief Executive Officer
- Anne Phillips, MD,
- Beth Seidenberg, MD,
- Elizabeth Grammer, Esq,
- Jennifer Jarrett,
- Merdad Parsey, MD, PhD,
- Paul Hoelscher,
- Tim Walbert,
Last updated: 2024-12-31
Salarius Pharmaceuticals, Inc.
Seclidemstat (SP-2577)
Salarius Pharmaceuticals, Inc. is a clinical-stage biotechnology company focusing on developing epigenetic-based cancer treatments, with its lead candidate, Seclidemstat, in Phase I/II clinical trials for advanced solid tumors and Ewing sarcoma.
Symbol: SLRX
Recent Price: $1.52
Industry: Biotechnology
CEO: Mr. David J. Arthur M.B.A.
Sector: Healthcare
Employees: 2
Address: 2450 Holcombe Boulevard, Houston, TX 77021
Phone: 832 834 6992
Last updated: 2024-12-31
Syros Pharmaceuticals, Inc.
Tamibarotene
Syros Pharmaceuticals is a biopharmaceutical company focused on developing treatments for cancer and monogenic diseases through gene control medicines. Key products include Tamibarotene for myelodysplastic syndrome and acute myeloid leukemia, and SY-5609 for advanced solid tumors.
About | Leadership | Directors | About | Contact | Careers | Vision/Values | DEI | Careers | About | About
Symbol: SYRS
Recent Price: $0.25
Industry: Biotechnology
CEO: Mr. Conley Chee
Sector: Healthcare
Employees: 68
Address: 35 CambridgePark Drive, Cambridge, MA 02140
Phone: 617 744 1340
Leadership
- Conley Chee, President and Chief Executive Officer
- Jason Haas, Chief Financial Officer
- Gerald E. Quirk, Chief Legal & Compliance Officer; Chief Business Officer
- Lisa Roberts, VP Human Resources
- David A. Roth, M.D., Chief Medical Officer
- Kristin Stephens, Chief Development Officer
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
2seventy bio, Inc.
idecabtagene vicleucel
2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.
Symbol: TSVT
Recent Price: $2.89
Industry: Biotechnology
CEO: Mr. William D. Baird III, M.B.A.
Sector: Healthcare
Employees: 274
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Last updated: 2024-12-31
Exelixis, Inc.
CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.
Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers
Symbol: EXEL
Recent Price: $33.70
Industry: Biotechnology
CEO: Dr. Michael M. Morrissey Ph.D.
Sector: Healthcare
Employees: 1310
Address: 1851 Harbor Bay Parkway, Alameda, CA 94502
Phone: 650 837 7000
Last updated: 2024-12-31